Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers

Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers

Abstract Breast cancer is the most common female tumors arising worldwide, and genetic and epigenetic events are constantly accumulated in breast tumorigenesis. The melastatin-related transient receptor potential 7 channel (TRPM7) is a nonselective cation channel, mainly maintaining Zn2+, Ca2+ and M...

Full description

Bibliographic Details
Main Authors: Yuanyuan Wang, Rong Lu, Pu Chen, Rongrong Cui, Meiju Ji, Xiaozhi Zhang, Peng Hou, Yiping Qu
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Cancer
Subjects:
Breast cancer
TRPM7
Promotor methylation
Methylation-Specific PCR (MSP)
Clinical outcomes
Online Access:https://doi.org/10.1186/s12885-022-10038-z

Internet

https://doi.org/10.1186/s12885-022-10038-z

Similar Items